Two Sigma Investments »

Cytokinetics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Cytokinetics shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $12M 8.5M 1.42
2024-12-31 $7.0M 5.9M 1.19

More positions owned by Two Sigma Investments

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr State Street Con (XLY)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Rivian Automotive Com Cl A (RIVN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Palantir Technologies Cl A (PLTR)
Echostar Corp Note 3.875%11/3 (Principal)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Vanguard Index Fds Real Estate Etf (VNQ)
Amazon (AMZN)

View all positions for Two Sigma Investments

Top funds holding Cytokinetics

Balyasny Asset Management
FMR
Lazard Asset Management
Two Sigma Investments
Wellington Management Company
Nuveen
Capstone Investment Advisors
Leucadia National Corporation
Goldman Sachs Group
Bnp Paribas Investment Partners
Advent Capital Management
Context Capital Management
Groupama Asset Managment
Jane Street
Shenkman Capital Management

View all funds holding Cytokinetics